Cardiac screening before returning to elite sport after SARS-CoV-2 infection |
| |
| Affiliation: | 1. PhyMedExp, University Montpellier, Inserm, CNRS; Cardiology and Physiology departments, University hospital Montpellier, Montpellier, France;2. Department of Sport Medicine, University hospital Pontchaillou; University Rennes 1, Inserm, LTSI-UMR 1099, Rennes, France;3. Sport Medicine Center “Mon Stade”, Paris, France;4. Cardiology Department, University Hospital of Dijon, Physiopathology and brain cardiovascular epidemiology (PEC2), EA7460, University of Bourgogne Franche-Comté, Dijon, France;5. PhyMedExp, University Montpellier, Inserm, CNRS, University hospital Nîmes, Nîmes, France;6. Department of Sport medicine, Hospital of Perpignan, Perpignan, France;7. Cardiology Department, Rangueil University Hospital, Toulouse, France;8. Cardio-respiratory rehabilitation center of Loire, St Priest en Jarez, France;9. IDESP, Inserm, University Montpellier, University hospital Montpellier, Montpellier, France;10. Cardiology practice, Montigny les Metz, France;11. Cardiology Department, Clinique du Millénaire, Montpellier, France;12. AP–HP Hôtel-Dieu University Hospital, Diagnosis and Therapeutic Center, Paris, France;13. INSEP, medical center, Paris, France;14. MOVE laboratory (UR 20296), Poitiers University of sciences and technology of physical activity and sports, Poitiers, France |
| |
| Abstract: | BackgroundSARS-CoV-2 infection can induce cardiac damage. Therefore, in the absence of clear data, a cardiac evaluation was recommended for athletes before returning to play after recent SARS-CoV-2 infection.AimTo assess the proportion of anomalies detected by this cardiac screening.MethodsWe reviewed the medical files of elite athletes referred for cardiac evaluation before returning to play after a non-hospitalized SARS-CoV-2 infection (based on a positive polymerase chain reaction or antigen test) from March 2020 to July 2021 in 12 French centres.ResultsA total of 554 elite athletes (professional or national level) were included (median age 22 years, 72.0% male). An electrocardiogram (ECG), echocardiogram and exercise test were performed in 551 (99.5%), 497 (89.7%) and 293 (52.9%) athletes, respectively. We found anomalies with a potential link with SARS-CoV-2 infection in four ECGs (0.7%), three echocardiograms (0.6%) and three exercise tests (1.0%). Cardiac magnetic resonance imaging was performed in 34 athletes (6.1%), mostly due to abnormal first-line examinations, and was abnormal in one (2.9%). The rates of those abnormalities were not higher among athletes with cardiac symptoms or more severe forms of non-hospitalized SARS-CoV-2 infection. Only one athlete had a possible SARS-CoV-2 myocarditis and sport was temporally contraindicated. None had a major cardiac event declared during the follow-up.ConclusionThe proportion of cardiac involvement after non-hospitalized forms of SARS-CoV-2 infection in athletes are very low. Systematic cardiac screening before returning to play seems to be unnecessary. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
